LetibotulinumtoxinA is a newly registered neuromodulator for the treatment of glabellar lines in Europe.*,2 Its efficacy and safety was evaluated in three identical randomized, double-blind, placebo-controlled, multicenter, phase 3 studies including

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In